Maximize Returns with AI-Powered VRTX Insights

VRTX Forecast

Bearish <—> Bullish

80% Confidence

Bullish Case: FDA-approved non-opioid painkiller Journavx could boost revenues, alongside strong CF portfolio and gene therapy agreements.

Bearish Case: Potential insider selling and high R&D costs might weigh on VRTX, compounded by competition in CF treatments.

Potential Outcomes: Journavx market adoption (60%), regulatory delays (30%), CF dominance (55%), increased competition (50%).

Trading Oracle: Execute a bullish debit spread: buy $460 call, sell $480 call with July 2025 expiry. Aligning with FDA approvals and low volatility, this strategy targets upside potential with balanced risk-reward.

February 18, 2025

Vertex Pharmaceuticals Forecast

VRTX Vertex Pharmaceuticals

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with VRTX

PPH VanEck Pharmaceutical (0.71)

LLY Lilly(Eli) (0.71)

XLV Health Care Select Sector SPDR (0.69)

KO Coca-Cola (0.68)

HPQ HP (0.66)

Uncorrelated Assets

Assets with little price relationship to VRTX

AXON Axon Enterprise (0.0)

SU Suncor Energy (-0.0)

VIR Vir Biotechnology (0.0)

ADM Archer Daniels Midland (-0.0)

GGAL Grupo Financiero Galicia (0.0)

Anticorrelated Assets

Assets that tend to move strongly against VRTX

LAC Lithium Americas (-0.59)

CRNC Cerence (-0.61)

YELP Yelp (-0.61)

LABD Direxion Daily S&P Biotech Bear 3X Shares (-0.63)

PATH UiPath (-0.65)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.